8 completed, 2 unknown, 1 terminated. 11 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 11 | Completed 8, Unknown 2, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Magnetic Resonance Imaging: new trials by email Literature Review of Magnetic Resonance Imaging trials Research Report on Magnetic Resonance Imaging
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Polyglycan Superparamagnetic Ferric Oxide Injection on Cardiovascular Magnetic Resonance Imaging Polysaccharide superparamagnetic ferric oxide injection - Magnetic Resonance Imaging, Chronic Kidney Diseases | Phase 1 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 30 | 2023-06-17 | 2023-06-27 |
| Material Balance Study of TQ-B3525 TQ-B3525 - Chronic Kidney Diseases, Magnetic Resonance Imaging | Phase 1 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 8 | 2023-01-01 | 2023-01-12 |
| Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients Polysaccharide superparamagnetic iron oxide injection - Diabetes, Magnetic Resonance Imaging | Phase 1 / Phase 2 | Completed | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 12 | 2021-11-06 | 2023-09-29 |
| Phase Ib, Administration the IOP Injection for MRI Contrast Agent in Healthy Subjects IOP Injection - Magnetic Resonance Imaging | Phase 1 | Completed | MegaPro Biomedical Co. Ltd. | 12 | 2018-04-01 | 2018-08-17 |
| Dexmedetomidine and Ketamine in MRI Dexmedetomidine, Ketamine - Magnetic Resonance Imaging | Phase 1 | Completed | Children's Hospital Medical Center, Cincinnati | 22 | 2016-06-01 | 2019-07-24 |
| Oral Pharmacokinetics of Sulfasalazine, Paracetamol, Fexofenadine and Valsartan Using Different Administration Mediums Paracetamol, Sulfasalazine, Fexofenadine - Pharmacokinetics, Magnetic Resonance Imaging | Phase 1 | Completed | University Medicine Greifswald | 9 | 2016-04-01 | 2017-01-06 |
| Phase I , MTD, Pharmacokinetic, Safety/Tolerability, Efficacy of IOP Injection for MRI in Healthy Subjects IOP Injection, 0.9% normal saline - Magnetic Resonance Imaging | Phase 1 | Completed | MegaPro Biomedical Co. Ltd. | 24 | 2016-02-01 | 2018-08-17 |
| Gadobutrol Pharmacokinetic and Safety Study in Pediatric Subjects Aged <2 Years (Term Newborn Infants to Toddlers 23 Months of Age Inclusive) Gadobutrol (Gadavist, BAY86-4875) - Magnetic Resonance Imaging | Phase 1 | Completed | Bayer | 44 | 2012-05-16 | 2020-12-16 |
| Two Anesthetic Techniques in Magnetic Resonance Imaging (MRI) dexmedetomidine, propofol - Magnetic Resonance Imaging, Anesthesia | Phase 1 | Terminated | Children's Hospital Medical Center, Cincinnati | 98 | 2009-01-01 | 2020-09-21 |
| Investigating the Acute Effects of THC on Functional Brain Systems Delta9-tetrahydrocannabinol (THC) - Reward, Tetrahydrocannabinol | Phase 1 | Completed | UMC Utrecht | 12 | 2008-04-01 | 2009-02-18 |
| A Study of Magnetic Resonance Imaging (MRI) With Gadavist in Children Gadobutrol (Gadavist, Gadovist, BAY86-4875) - Magnetic Resonance Imaging | Phase 1 | Completed | Bayer | 140 | 2007-05-01 | 2015-07-22 |
Renal Insufficiency, Chronic (2) · Diabetes Mellitus (1)
Chronic Disease (2) · Disease Attributes (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Renal Insufficiency (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Dexmedetomidine (2) · gadobutrol (2) · Acetaminophen (1) · Dronabinol (1) · Ketamine (1) · Propofol (1) · Saline Solution (1) · Sodium Chloride (1) · Sulfasalazine (1) · TQ-B3525 (1) · Valsartan (1) · fexofenadine (1)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (3) · Bayer (2) · Children's Hospital Medical Center, Cincinnati (2) · MegaPro Biomedical Co. Ltd. (2) · UMC Utrecht (1) · University Medicine Greifswald (1)
China (3) · United States (3) · Canada (2) · Germany (2) · Taiwan (2) · Austria (1) · Netherlands (1) · Sweden (1)
Mohamed Mahmoud, MD (1) · Nick Ramsey, Professor (1) · Rheun-Chuan Lee (1) · Rheun-Chuan Lee, MD (1)